SAN MATEO, Calif., April 14, 2020 /PRNewswire/ — Lumiata uses artificial intelligence to address the cost and risk of healthcare for customers. As the provider of an AI-powered platform and models for the healthcare industry, Lumiata accelerates its focus on the world’s most pressing issue, COVID-19, with the Lumiata COVID-19 Global AI Hackathon.
Lumiata COVID-19 Global AI Hackathon
Lumiata invites data scientists, machine learning practitioners, developers, health IT professionals, public health experts and others around the globe, to participate in the hackathon and address current challenges posed by COVID-19 and/or the future impact of COVID-19 on global healthcare.
All hackathon entries will be judged by a panel recognized AI thought leaders from across the globe.
Aneesh Chopra
President, Care Journey
Former United States CTO
Obama Administration
Edward Frenkel
Professor of Mathematics,
University of California, Berkeley
Member, American Academy
of Arts and Sciences,
Author, Love and Math
Chris Gough
General Manager,
Intel Health & Life Sciences
Aashima Gupta
Global Director, Healthcare Solutions
Google Cloud
Junling Hu
Founder and CTO, Question.ai
Author, The Evolution of Artificial Intelligence
Vinod Khosla
Founder, Khosla Ventures
Katherine Klein
Edward H. Bowman Professor
Professor of Management
Vice-Dean, Wharton
Social Impact Initiative
Bill Lucia
Chairman & CEO, HMS
Severence M. MacLaughlin
Managing Director,
DeLorean Artificial Intelligence
Lisa Suennen
Leader, Manatt Digital and Technology
Leader, Venture Capital/Emerging Companies Practice
“Data is fuel, an asset in today’s healthcare world, where AI helps develop solutions that address cost and risk to improve patient outcomes,” said Dilawar Syed, CEO of Lumiata. Syed explained that the potential to use AI for COVID-19 solutions led to the hackathon.
Ideas for these potential solutions, judging criteria, data requirements and sources, judging panel and other information appear on the COVID-19 Global AI Hackathon website. Winners will be announced on May 8 with winning solutions hosted on the Lumiata AI platform with full credit to the developer.
“We designed the hackathon to encourage the many talented minds across the globe to address the challenges of COVID-19 using AI,” said Syed. “These talented experts can develop their own ideas using AI to address the challenges of this public health crisis.”
Visit the Lumiata COVID-19 Global AI Hackathon page for more information and to register. Follow the hackathon at #LumiataCOVID19.
About Lumiata
Lumiata delivers solutions to meet the needs of public and private health care for today and tomorrow. Based in the heart of Silicon Valley, Lumiata is an Artificial Intelligence company purpose-built for the healthcare industry. Powered by over 100 million patient data records, clinical, risk, and financial algorithms, Lumiata employs some of the nation’s leading data science and machine learning talent. Lumiata enriches payers’ and providers’ analytic and predictive capabilities with tools and pre-trained models that help to manage healthcare costs and risk. For more information, visit lumiata.com or follow @lumiata on Twitter.
For Lumiata inquiries, please contact:
Jessica McCarthy
Vice President of Marketing
237926@email4pr.com
(415) 350-7118
View original content to download multimedia:http://www.prnewswire.com/news-releases/lumiata-brings-ai-to-the-forefront-with-covid-19-global-ai-hackathon-301040121.html
SOURCE Lumiata
London, United Kingdom--(Newsfile Corp. - June 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…
Americans Save Big on Wegovy with Canadian Insulin’s Prescription Referral Service REGINA, SK / ACCESSWIRE…
NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Merck & Co., Inc.Strong career paths…
The new partnership brings Pearl’s industry-leading dental AI capabilities to groundbreaking new all-in-one practice management…
Prior CEO and Founder, Dr. John Simpson, to Remain with Company as Chief Medical Officer…
The collaboration will bring clinical insights across the patient health journey for over 320,000 annual…